Search

Your search keyword '"Enriz RD"' showing total 110 results

Search Constraints

Start Over You searched for: Author "Enriz RD" Remove constraint Author: "Enriz RD"
110 results on '"Enriz RD"'

Search Results

51. Small Peptides Derived from Penetratin as Antibacterial Agents.

52. Theoretical and Experimental Study of Inclusion Complexes of β-Cyclodextrins with Chalcone and 2',4'-Dihydroxychalcone.

53. Pentameric models as alternative molecular targets for the design of new antiaggregant agents.

54. New mimetic peptides inhibitors of Αβ aggregation. Molecular guidance for rational drug design.

55. 3-Chlorotyramine Acting as Ligand of the D2 Dopamine Receptor. Molecular Modeling, Synthesis and D2 Receptor Affinity.

56. A new series of antibacterial nitrosopyrimidines: synthesis and structure-activity relationship.

57. The dynamic action mechanism of small cationic antimicrobial peptides.

58. Structural and functional insights into the anti-BACE1 Fab fragment that recognizes the BACE1 exosite.

59. 2,3,9- and 2,3,11-trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands.

60. Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration.

61. Penetratin and derivatives acting as antibacterial agents.

62. Structural requirements for the antifungal activities of natural drimane sesquiterpenes and analogues, supported by conformational and electronic studies.

63. Cinnamic acid derivatives acting against Aspergillus fungi. Taq polymerase I a potential molecular target.

64. Structure-activity relationship study of nitrosopyrimidines acting as antifungal agents.

65. Catalytic and molecular properties of rabbit liver carboxylesterase acting on 1,8-cineole derivatives.

66. Amyloid-β fibril disruption by C60-molecular guidance for rational drug design.

67. Tetrahydroisoquinolines acting as dopaminergic ligands. A molecular modeling study using MD simulations and QM calculations.

68. Searching the "biologically relevant"conformation of dopamine: a computational approach.

69. Penetratin analogues acting as antifungal agents.

70. Structural and thermodynamic characteristics of the exosite binding pocket on the human BACE1: a molecular modeling approach.

71. New antifungal peptides. Synthesis, bioassays and initial structure prediction by CD spectroscopy.

72. Antifungal activity of extracts and prenylated coumarins isolated from Baccharis darwinii Hook & Arn. (Asteraceae).

73. New small-size peptides possessing antifungal activity.

74. Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives.

75. Ab initio and DFT study of the conformational energy hypersurface of cyclic Gly-Gly-Gly.

76. In silico study of full-length amyloid beta 1-42 tri- and penta-oligomers in solution.

77. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.

78. Penetratin and derivatives acting as antifungal agents.

79. A comprehensive conformational analysis of bullacin B, a potent inhibitor of complex I. Molecular dynamics simulations and ab initio calculations.

80. Structure-antifungal activity relationship of His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 and analogues.

81. Antioxidant and cytotoxic activities of canadine: biological effects and structural aspects.

82. Synthesis, dopaminergic profile, and molecular dynamics calculations of N-aralkyl substituted 2-aminoindans.

83. Ring inversion in 1,4,7 cyclononatriene and analogues: Ab initio and DFT calculations and topological analysis.

84. Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.

85. Conformational preferences of N-acetyl-L-leucine-N'-methylamide. Gas-phase and solution calculations on the model dipeptide.

86. New antitumoral acetogenin 'Guanacone type' derivatives: isolation and bioactivity. Molecular dynamics simulation of diacetyl-guanacone.

87. Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.

88. Synthesis and conformational analysis of His-Phe-Arg-Trp-NH2 and analogues with antifungal properties.

89. Structure-activity relationship study of homoallylamines and related derivatives acting as antifungal agents.

90. Dynamics of flexible cycloalkanes. Ab initio and DFT study of the conformational energy hypersurface of cyclononane.

91. Gastric cytoprotective activity of ilicic aldehyde: structure-activity relationships.

92. An exhaustive conformational analysis of N-acetyl-L-cysteine-N-methylamide. Identification of the complete set of interconversion pathways on the ab initio and DFT potential energy hypersurface.

93. In vitro antifungal properties structure-activity relationships and studies on the mode of action of N-phenyl, N-aryl, N-phenylalkyl maleimides and related compounds.

94. Cytotoxic and apoptotic effects on hepatocytes of secondary metabolites obtained from lichens.

95. In vitro-in vivo antifungal evaluation and structure-activity relationships of 3H-1,2-dithiole-3-thione derivatives.

96. Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla.

97. In vitro antifungal activity of new series of homoallylamines and related compounds with inhibitory properties of the synthesis of fungal cell wall polymers.

98. Synthesis, in vitro/in vivo antifungal evaluation and structure-activity relationship study of 3(2H)-pyridazinones.

99. Syntheses and antitumor targeting G1 phase of the cell cycle of benzoyldihydroisoquinolines and related 1-substituted isoquinolines.

100. In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall.

Catalog

Books, media, physical & digital resources